Medical Journals

Inhibitory Effect of Tocotrienol on Eukaryotic Dna Polymerase Lambda and Angiogenesis.

Authors:
  • Mizushina Yoshiyuki
  • Nakagawa Kiyotaka
  • Shibata Akira
  • Awata Yasutoshi
  • Kuriyama Isoko
  • Shimazaki Noriko
  • Koiwai Osamu
  • Uchiyama Yukinobu
  • Sakaguchi Kengo
  • Miyazawa Teruo
  • Yoshida Hiromi

From: Laboratory of Food and Nutritional Sciences, Department of Nutritional Science, Kobe-Gakuin University, Nishi-ku, Kobe, Hyogo 651-2180, Japan. mizushin@nutr.kobegakuin.ac.jp

Biochemical and biophysical research communications

  • Publish Date: Jan 2006
  • ISSN: 0006-291X
  • Volume: 339
  • Issue: 3
  • Pages: 949-55
  • Medium: Print
  • Language: English
  • Citation (JAMA): Mizushina Yoshiyuki, Nakagawa Kiyotaka, Shibata Akira, et al. Inhibitory Effect of Tocotrienol on Eukaryotic Dna Polymerase Lambda and Angiogenesis.. Biochem. Biophys. Res. Commun. Jan 2006;339:949-55

Abstract

Tocotrienols, vitamin E compounds that have an unsaturated side chain with three double bonds, selectively inhibited the activity of mammalian DNA polymerase lambda (pol lambda) in vitro. These compounds did not influence the activities of replicative pols such as alpha, delta, and epsilon, or even the activity of pol beta which is thought to have a very similar three-dimensional structure to the pol beta-like region of pol lambda. Since delta-tocotrienol had the strongest inhibitory effect among the four (alpha- to delta-) tocotrienols, the isomer’s structure might be an important factor in the inhibition of pol lambda. The inhibitory effect of delta-tocotrienol on both intact pol lambda (residues 1-575) and a truncated pol lambda lacking the N-terminal BRCA1 C-terminus (BRCT) domain (residues 133-575, del-1 pol lambda) was dose-dependent, with 50% inhibition observed at a concentration of 18.4 and 90.1microM, respectively. However, del-2 pol lambda (residues 245-575) containing the C-terminal pol beta-like region was unaffected. Tocotrienols also inhibited the proliferation of and formation of tubes by bovine aortic endothelial cells, with delta-tocotrienol having the greatest effect. These results indicated that tocotrienols targeted both pol lambda and angiogenesis as anti-cancer agents. The relationship between the inhibition of pol lambda and anti-angiogenesis by delta-tocotrienol was discussed.

Mesh Headings (Keywords): Animals, Cattle, Cell Proliferation, Cells, Cultured, DNA Polymerase III, DNA Polymerase beta, Dose-Response Relationship, Drug, Endothelial Cells, Enzyme Inhibitors, Neovascularization, Physiologic, Tocotrienols


Check for Full Text / PubMed Unique Identifier (PMID): 16325764


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.